Personal
Mohamed H. Nabulsi, Healthcare Chair at Mandelbaum Barrett, represents healthcare providers, organizations and entrepreneurs in complex healthcare transactions, strategic affiliations, regulatory matters, governmental investigations, and high-stakes litigation throughout the U.S. His clients include individual providers and group practices of all disciplines, LTACH and general hospitals, ASCs, imaging centers, labs, pharmacies, ABA clinics, SUD and BH facilities, SNFs, hospice and home health agencies, DME providers, management and billing companies, real estate, and software companies.
Mr. Nabulsi is widely recognized for his work on transformative healthcare transactions. Notably, he served as lead healthcare and M&A counsel in the nine-figure acquisition of the CarePoint Health System through Chapter 11 proceedings on behalf of Hudson Regional Hospital, resulting in the creation of a four-hospital health system.
A substantial portion of Mr. Nabulsi’s practice is devoted to physician alignment, strategic affiliations and healthcare consolidations. He regularly advises clients on acquisitions, joint ventures, investment transactions, management structures, and long-term affiliations.
Mr. Nabulsi also counsels on challenging regulatory and reimbursement matters, including compliance with fraud and abuse laws, HIPAA, Medicare and Medicaid requirements, provider enrollment issues, reimbursement disputes, and provides defense vis-à-vis governmental investigations.
Mr. Nabulsi has set precedent in healthcare litigation including a landmark victory before the United States Court of Appeals for the 3rd Circuit against GEICO. Mr. Nabulsi is at the forefront of litigation involving the federal NSA and the IDR process.
Philanthropically, Mr. Nabulsi operates the Nabulsi Family Foundation, a charitable organization dedicated to advancing healthcare, education, humanitarian relief, and animal welfare initiatives.
Publications
“FTC’s Labor-market Rule Ends Most Noncompetes for Physicians, If It Clears” Part B News, May 2, 2024
“The Non-compete Ban and Your Practice” Physicians Practice, April 26, 2024
“IRS Crackdown Shows Your Covid Program Responsibilities Aren’t Over” Part B News, October 5, 2023
“The recent uptick in False Claims Act investigations explained,” Medical Economics, February 24, 2023.
“Fighting Back: Facing extinction amid monopolization, independent pharmacies see a lifeline,” NJBIZ, January 17, 2022.